Sohag faculty of medicine
Sohag, Egypt
Location status: Recruiting
NCT Number: NCT06673381
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
Interested in participating?
Request Info18 year and older
All sexes
Observational
Sohag, Egypt
Location status: Recruiting
Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU.
Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured.
hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at time of admission in hospital
Venous blood samples were collected on admission to the hospital. hs-CRP , serum albumin level were measured.
hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR)
Contact information is provided by the study sponsor or research team.
Sohag University
Other
Prediction of Acute Coronary Syndrome In-hospital Major Adverse Cardiovascular Events by High Sensitivity C- Reactive Protein to Albumin Ratio
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258290
Acute Coronary Syndrome, Angina Pectoris
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07032389
Acute Coronary Syndrome, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT06332859
Acute Coronary Syndrome, Cardiomyopathies
Bad Tatzmannsdorf, Burgenland, Austria
View Trial DetailsNCT01311323
Acute Coronary Syndrome, Cardiovascular Diseases
Chrzanów, Malopolska, Poland
View Trial Details